NCT03019939 Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia Status COMPLETED Phase PHASE2
NCT02967341 Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer Patients Status UNKNOWN Phase PHASE4
NCT02953340 SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide Status COMPLETED Phase PHASE3
NCT02912117 Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay Status COMPLETED Phase N/A
NCT02872103 Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy Status COMPLETED Phase PHASE3
NCT02755857 Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis Status COMPLETED Phase PHASE2
NCT02685111 Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) Status TERMINATED Phase PHASE2
NCT02679443 Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy Status COMPLETED Phase NA
NCT02643420 SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE) Status COMPLETED Phase PHASE3
NCT02629289 A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants Status COMPLETED Phase PHASE1
NCT02621905 Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mg Status COMPLETED Phase PHASE4
NCT02589301 Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations Status COMPLETED Phase PHASE1
NCT02544685 Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients Status UNKNOWN Phase PHASE2
NCT02544230 Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia Status COMPLETED Phase N/A
NCT02527746 Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy Status COMPLETED Phase PHASE1
NCT02522234 A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy Status COMPLETED Phase PHASE1/PHASE2
NCT02521441 A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy. Status COMPLETED Phase PHASE2
NCT02452034 Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097) Status COMPLETED Phase PHASE1